QUESTCOR PHARMACEUTICALS INC's ticker is QCOR and the CUSIP is 74835Y101. A total of 332 filers reported holding QUESTCOR PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 4.70 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $459,407,000 | +74.4% | 4,967,086 | +22.4% | 0.20% | +63.6% |
| Q1 2014 | $263,421,000 | +15.8% | 4,057,018 | -2.9% | 0.12% | +15.2% |
| Q4 2013 | $227,538,000 | +10.3% | 4,178,842 | +17.5% | 0.10% | -3.7% |
| Q3 2013 | $206,221,000 | +67.4% | 3,555,535 | +31.2% | 0.11% | +53.5% |
| Q2 2013 | $123,214,000 | – | 2,710,375 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,296,660 | $149,800,000 | 34.05% |
| Valiant Capital Management, L.P. | 913,693 | $41,518,000 | 4.98% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 366,625 | $16,659,000 | 4.35% |
| Freshford Capital Management, LLC | 575,000 | $26,128,000 | 3.87% |
| Palo Alto Investors LP | 696,297 | $31,640,000 | 3.73% |
| RIVULET CAPITAL, LLC | 100,000 | $4,544,000 | 3.62% |
| CAPITAL MANAGEMENT CORP /VA | 190,135 | $8,640,000 | 3.59% |
| Consonance Capital Management LP | 200,000 | $9,088,000 | 3.23% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 407,400 | $18,513,000 | 2.70% |
| Freestone Capital Holdings, LLC | 268,738 | $12,211,000 | 2.50% |